| Key Financial Ratios of AstraZeneca Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
46.30 |
64.60 |
39.70 |
24.60 |
37.30 |
|
| Diluted EPS (Rs.) |
46.30 |
64.60 |
39.70 |
24.60 |
37.30 |
|
| Cash EPS (Rs.) |
62.29 |
70.58 |
46.22 |
31.42 |
45.37 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
308.14 |
284.77 |
235.48 |
204.56 |
182.47 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
308.14 |
284.77 |
235.48 |
204.56 |
182.47 |
|
| Dividend / Share(Rs.) |
32.00 |
24.00 |
16.00 |
10.00 |
2.00 |
|
| Revenue from Operations/Share (Rs.) |
686.52 |
518.21 |
401.19 |
322.24 |
325.42 |
|
| PBDIT/Share (Rs.) |
117.84 |
87.70 |
76.49 |
40.38 |
59.32 |
|
| PBIT/Share (Rs.) |
101.84 |
81.72 |
69.98 |
33.60 |
51.27 |
|
| PBT/Share (Rs.) |
62.54 |
87.82 |
53.64 |
33.22 |
50.84 |
|
| Net Profit/Share (Rs.) |
46.30 |
64.60 |
39.72 |
24.64 |
37.32 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
17.16 |
16.92 |
19.06 |
12.52 |
18.22 |
|
| PBIT Margin (%) |
14.83 |
15.77 |
17.44 |
10.42 |
15.75 |
|
| PBT Margin (%) |
9.11 |
16.94 |
13.37 |
10.30 |
15.62 |
|
| Net Profit Margin (%) |
6.74 |
12.46 |
9.89 |
7.64 |
11.46 |
|
| Return on Networth / Equity (%) |
15.02 |
22.68 |
16.86 |
12.04 |
20.45 |
|
| Return on Capital Employed (%) |
31.23 |
28.34 |
29.11 |
16.03 |
27.20 |
|
| Return on Assets (%) |
7.62 |
14.98 |
10.08 |
7.19 |
12.04 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
1.32 |
1.26 |
1.09 |
0.99 |
105.01 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.91 |
2.61 |
2.18 |
2.12 |
2.04 |
|
| Quick Ratio (X) |
1.13 |
1.97 |
1.68 |
1.70 |
1.51 |
|
| Inventory Turnover Ratio (X) |
4.42 |
0.62 |
0.51 |
0.60 |
5.09 |
|
| Dividend Payout Ratio (NP) (%) |
51.84 |
24.76 |
20.14 |
8.11 |
5.35 |
|
| Dividend Payout Ratio (CP) (%) |
38.52 |
22.66 |
17.30 |
6.36 |
4.40 |
|
| Earnings Retention Ratio (%) |
48.16 |
75.24 |
79.86 |
91.89 |
94.65 |
|
| Cash Earnings Retention Ratio (%) |
61.48 |
77.34 |
82.70 |
93.64 |
95.60 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
20,979.18 |
12,795.16 |
7,617.77 |
5,940.17 |
7,173.15 |
|
| EV/Net Operating Revenue (X) |
12.22 |
9.88 |
7.60 |
7.37 |
8.82 |
|
| EV/EBITDA (X) |
71.21 |
58.36 |
39.84 |
58.85 |
48.37 |
|
| MarketCap/Net Operating Revenue (X) |
12.54 |
10.27 |
8.09 |
7.93 |
9.25 |
|
| Retention Ratios (%) |
48.15 |
75.23 |
79.85 |
91.88 |
94.64 |
|
| Price/BV (X) |
27.93 |
18.68 |
13.79 |
12.49 |
16.50 |
|
| Price/Net Operating Revenue |
12.54 |
10.27 |
8.09 |
7.93 |
9.25 |
|
| Earnings Yield |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
|
Source : Dion Global Solutions Limited
